$319.00 – $836.00
MEF cells serve as feeder cells that support the growth of undifferentiated mouse or human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). MEF cells are isolated from 13.5-day old mouse embryos and should be used at early passages. Before use as feeder cells, MEF cells must be mitotically inactivated by γ-irradiation or mitomycin-C treatment.
DR4 MEF cells are derived from mice genetically engineered with four drug-resistant genes: neomycin, hygromycin, puromycin, and 6-thioguanine.
Background: 129P2/OlaHsd, 129S4/SvJae, BALB/c and C57BL/6
| Table Header | Table Header |
|---|---|
|
Passage |
P2 |
|
Treatment |
Untreated |
| Cat. # | Cells per vial | Number of vials |
|---|---|---|
|
ASF-1001 |
1 x 106 cells/vial |
1 vial |
|
ASF-1002 |
1 x 106 cells/vial |
3 vials |
Fill out the contact form below and a team member will be in touch within one business day.
